CompanyProfileNomu
Actions
Lana Medical Co.
- Nomu - Parallel Market
- Health Care Equipment & Svc
Stats Overview
-
Prev. Close 41.85
-
Open 41.80
-
High 41.80
-
Low 41.80
-
No. Of Trades 10
-
Avg. Trade size* 39
-
Volume Traded 391
-
Value Traded 15,908.05
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Trade Updates
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select A Maximum Of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|
CompanyProfileNomuv2Financials
Actions
- Announcements & Corporate Actions
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Semi-Annual
| Balance Sheet | ||||
|---|---|---|---|---|
| Total Assets | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) | - | - | - | - |
| Total Liabilities and Shareholders Equity | - | - | - | - |
| Statement of Income | ||||
| Total Revenue (Sales/Operating) | - | - | - | - |
| Net Profit (Loss) before Zakat and Tax | - | - | - | - |
| Zakat and Income Tax | - | - | - | - |
| Net Profit (Loss) after Zakat and Tax | - | - | - | - |
| Total Comprehensive Income | - | - | - | - |
| Profit (Loss) per Share | - | - | - | - |
| Cash Flow | ||||
| Net Cash From Operating Activities | - | - | - | - |
| Net Cash From Investing Activities | - | - | - | - |
| Net Cash From Financing Activities | - | - | - | - |
| Cash and Cash Equivalents, Beginning of the Period | - | - | - | - |
| Cash and Cash Equivalents, End of the Period | - | - | - | - |
| All Figures in | ||||
| All Currency In | ||||
| Last Update Date |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | ||||
|---|---|---|---|---|
| Total Assets | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) | - | - | - | - |
| Total Liabilities and Shareholders Equity | - | - | - | - |
| Statement of Income | ||||
| Total Revenue (Sales/Operating) | - | - | - | - |
| Net Profit (Loss) before Zakat and Tax | - | - | - | - |
| Zakat and Income Tax | - | - | - | - |
| Net Profit (Loss) after Zakat and Tax | - | - | - | - |
| Total Comprehensive Income | - | - | - | - |
| Profit (Loss) per Share | - | - | - | - |
| Cash Flow | ||||
| Net Cash From Operating Activities | - | - | - | - |
| Net Cash From Investing Activities | - | - | - | - |
| Net Cash From Financing Activities | - | - | - | - |
| Cash and Cash Equivalents, Beginning of the Period | - | - | - | - |
| Cash and Cash Equivalents, End of the Period | - | - | - | - |
| All Figures in | ||||
| All Currency In | ||||
| Last Update Date |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
The companys activity is trading in medical and cosmetic devices medical supplies and treating medical waste
Company History
A closed joint stock company established under Commercial Registration No 1010289410 dated June 5 2010
Company Bylaws
Equity Profile
- Authorized Capital (SAR) 36,000,000
- Issued Shares 3,600,000
- Paid Up Capital (SAR) 36,000,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2023-12-05
Investment limits
There are no restrictions on the companys shares according to what is stated in both the rules regulating the investment of qualified foreign financial institutions in listed securities and the instructions regulating foreign strategic investors ownership of strategic shares in listed companies in accordance with the companys bylaws and the instructions issued by the supervisory and regulatory authorities to which the company is subject
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
SALMAN SALEH AL FAWZAN
Company Address:
RIYADH AS SULAY DISTRICT
Contact Details:
Telephone: 00966114755573
Fax: 00966114755579
Email: info@lanamedical.com
Company Website:
| Name Of Subsidiary | Percentage Of Property | Main Business | Location Of Operation | Country Of Operation |
|---|---|---|---|---|
| NEW LINES COMPANY | 100.00% | CONSTRUCTION | RIYADH | saudi arabia |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.